Daewoong Pharmaceutical Company Research Report

1. Company Overview

Name: Daewoong Pharmaceutical Co., Ltd.

Mission: The mission of Daewoong Pharmaceutical is to contribute to the improvement of quality of life by providing total solutions including pharmaceuticals and services in the most valuable way.

Founded: 1945

Founder: The company was founded under the philosophy of 'making good medicine to protect the health of the people and create a healthy society' known as '의약보국 (Medicine and Health Promotion)'.

Key People: The company is currently led by co-representatives Jeon Seung-ho and Lee Chang-jae, with Yoon Jae-chun serving as the Vice Chairman of Daewoong Co., Ltd.

Headquarters: The company is headquartered at 12, Bongeunsa-ro 114-gil, Gangnam-gu, Seoul, Korea.

Number of Employees: No information is available.

Revenue: As of 2023, Daewoong Pharmaceutical reported total assets of approximately 1,770.311 billion KRW, with total liabilities of about 858.03 billion KRW and equity of around 912.281 billion KRW.

Known For: Daewoong Pharmaceutical is recognized for its pioneering role in healthcare with a focus on R&D innovation and the development of new pharmaceutical products including chemical, biotech, and stem cell therapies.

2. Products

Daewoong Pharmaceutical provides a diverse range of products across several pharmaceutical categories including:

Over-the-Counter (OTC) Medicines

• Daewoong Urusa Soft Capsule

• Description: A product aimed at improving liver function and alleviating symptoms such as chronic fatigue and systemic weakness.

• Key Features: Contains Ursodeoxycholic acid as a primary component.

• Impactamin Premium Tablet

• Description: Designed for the tailored intake of Vitamin B and recommended for fatigue recovery, among other benefits.

• Key Features: Combines essential vitamin B complexes and ingredients like magnesium and Vitamin D.

Prescription Medicines

• Fexuclu Tablet

• Description: A treatment for erosive gastroesophageal reflux disease.

• Key Features: Fexuprazan hydrochloride is the main active ingredient.

• Enblo Tablet

• Description: A medication aimed at enhancing blood sugar control in patients with type 2 diabetes.

• Key Features: Contains Enavogliflozin as the active compound.

Health Supplements

• Energy Milk Thistle

• Description: Combines eight types of Vitamin B and Milk Thistle for energy generation and liver health.

• Key Features: Supports energy production and maintenance of liver health.

• Senomega Plant-Al-Ti Omega 3

• Description: Odorless plant-based omega-3 supplement containing EPA and DHA.

• Key Features: 100% plant-based omega-3 source.

3. Recent Developments

Recent News and Developments

• Product Launches: The company introduced "Nabotox" in the market, including launches in Malaysia, and plans for "Daewoong Noseguard Spray" using innovative components such as Xanthomonas campestris fermentation extract.

• Partnerships and Collaborations: A significant collaboration includes a joint venture with Oncorus for mRNA anticancer drug research.

• Innovations and Achievements: Within recent years, 88% of patents were related to new drugs, showcasing higher R&D innovation. The company received awards for executing independent and competitive R&D processes.

• Technological Advances: Daewoong unveiled "DAISY", an AI system for new drug development, and has been advancing its technology in sustained release injectable formulations and microneedle platforms.

• Sustainability and Corporate Responsibility: The company has been acknowledged for its ESG management practices, receiving accolades in the global ESG Human Rights Management category.

R&D Highlights

• Daewoong continues to focus on developing first/best-in-class innovative drugs through active collaboration in open innovation models, focusing on strategic therapeutic areas such as fibrotic diseases, metabolic disorders, and immune-related conditions.

• The company aims to reach a global top 20 position in areas including autoimmune, cancer, metabolic, and fibrotic research with ongoing efforts in R&D for breakthroughs in these fields.

These developments underscore Daewoong Pharmaceutical’s strategic focus on expanding its footprint in international markets, bolstering its product lineup with innovative solutions, and enhancing its R&D framework for continued global success and sustainability in healthcare solutions.